Tag: BIT

Biotron ASX BIT Phase 2 trial results HIV drug BIT225 Conference on Retroviral and Opportunistic Infections CROI

Biotron presents further phase 2 trial results for HIV drug BIT225

Clinical stage company Biotron (ASX: BIT) is preparing to present results from its ongoing phase 2 trial into its lead BIT225 drug at the annual...
Biotron ASX BIT coronavirus test compounds

Biotron to commence testing of compounds to destroy coronavirus

Australian clinical stage company Biotron (ASX: BIT) has announced it will commence the evaluation of “several promising compounds” which could target various strains of...
Biotron ASX BIT Phase 2 clinical trial success HIV drug biotech shares

Biotron rides wave of Phase 2 clinical trial success for HIV drug

Biotechnology company Biotron (ASX: BIT) is enjoying its moment in the sun on the back of a skyrocketing share price since news of a...

RECENT POSTS

STOCK SUMMARY

FOLLOW US

HOT TOPICS

TRENDING POSTS